1:04:27 Summing Up GLP-1s and Mental Health Dr
In 2023, branded obesity drug sales reached $6 billion, and this figure is expected to grow exponentially as demand continues to rise and these medications are used to treat a broader range of diseases
Like me, theyve turned to research-grade peptides labeled not for human consumption, shipped from overseas suppliers with no prescriptions, no oversight, and no guarantees
Gaps in state budgets shouldnt be closed by compromising the health of the underserved, communities of color, those with disabilities, and millions of others who depend on public healthcare coverage
A 2A receptor antagonism also has potential in reducing neuroinflammation and promoting solute clearance following CNS injury [423]